Documente Academic
Documente Profesional
Documente Cultură
Types of RNA?
Messenger RNA (mRNA): the coded instructions by the mRNA
Transfer RNA (tRNA) is responsible for bringing amino acids.
Ribosomal RNA (rRNA) is a component of the ribosome factory
Central Dogma of Biology
Central Molecular Biology Technologies :
2. Centrifugation
3. Hybridization
5. Gel Electrophoresis
6. Spectrophotometry
7. Sequencing
8. Flowcytometry
Polymerase Chain Reaction (PCR)
Examples
Important Applications
FISH
CGH
ELISA
ChIP
SNP arrays
Methylations arrays
Centrifugation
The centrifuge works using
the sedimentation principle, where the
centrifugal acceleration causes denser
substances and particles to move
outward in the radial direction. At the
same time, objects that are less dense
are displaced and move to the centre.
Gel Electrophoresis
Separates :
Large molecules from small
Based on electrical charge
Can be Direct or
Indirect
Through:
Virus
Liposomes
Direct DNA
Tried in :
Salivary glands to
correct systemic single
gene disorders.
I. Eg GH, Insulin, H3,
Aquaporins
II. Sjogren’s Syndrome
III. Pain
IV. P53 gene
2. Immunization
Examples:
I. Plasmids containing fimbrial gene for P. Gingivalis leadinding to
production of antibodies. Potentially useful in Periodotitis and
Dental Caries
3. Recombinant DNA technology
Example
I. Production of transgenic strains of Streptococcus mutans which lack the
specific gene required to produce decay.
I. Cleft Lip/Palate
II. Malocclusion
5. FORENSIC ODONTOLOGY
1. Identification/DNA profiling
2. Sex Determination
3. Patternity/Family Tree
4. Anthropological studies as Ethnicity, Migration patterns
Genetics in Periodontal Diseases
RECENT ADVANCES
1) Biochips
2) Human cloning
3) Transcriptome analysis
4) Metabolomics
5) Proteomics
6) Nutrigenomics
BIOCHIPS/KITS
MyPerioPath®
a. Detects (from bacterial DNA) the specific bacteria known to cause
periodontal inflammation and destruction
b. Eleven species fall within this group
c. Sub–divides these bacteria into “risk” groups based on known
risk/virulence properties: high, moderate, low
d. Determines concentration/bacterial load. (e.g., inflammatory burden).
e. Helps to determine therapy options based on bacterial risk assessment
MyPerioID® PST®
a. Detects (from human DNA) genetic variation/polymorphism within the IL–1
gene
b. IL–1 is a major inflammatory mediator
c. 30% to 35% of the U.S. population has this genetic variation
d. IL–1 positive individuals tend to have more aggressive and more severe
infections
e. Determines patients that are most susceptible to severe disease, especially if
the patients smoke
f. This genetic variation can increase risk for severe disease or tooth loss by 2 to
7 times when present
OraRisksm HPV
a. HPV (Human Papilloma Virus) is now a known risk factor for oropharyngeal
carcinoma of the mouth and throat
b. HPV can cause cancer of the mouth and throat regions
c. Provides information to triage patient for high risk HPV without or with
lesions
d. Detects those with HPV infections
e. Genotypes HPV based on known risk: high, low, unknown
f. Should be included in risk assessment for oral cancer in conjunction with
clinical exam, adjunctive tests, and history of alcohol and tobacco.
Kits for Measuring Caries Susceptibility/Activity